Tesamorelin

Tesamorelin – Synthetic GHRH Analogue (Product Code: TES‑001)

Unlock precise control over growth hormone pathways in your laboratory investigations with Tesamorelin, a high‑purity synthetic analogue of the endogenous Growth Hormone‑Releasing Hormone (GHRH). Engineered for reproducible performance, this peptide supports rigorous studies of endocrine signaling, receptor dynamics, and downstream cellular effects.

What it is

Tesamorelin (sequence: HSDGTFTSELSRLREGARLQRLLQGLV) is a chemically synthesized peptide that mirrors the biological activity of native GHRH. Delivered as a lyophilized powder, it is available in a defined quantity of 5 mg per vial, with purity verified by analytical HPLC and mass spectrometry. The product meets the stringent specifications required for high‑resolution research applications, ensuring consistency across experiments and laboratories.

• Validated purity: ≥ 95 % purity confirmed by HPLC, with full‑length mass confirmed by LC‑MS.
• Stable formulation: Lyophilized to protect peptide integrity; reconstitutes readily in standard aqueous buffers.
• Precise sequence: Exact amino‑acid composition (HSDGTFTSELSRLREGARLQRLLQGLV) enables reliable receptor binding studies.
• Scalable supply: Consistent batch‑to‑batch production supports both small‑scale pilot work and larger experimental series.
• Comprehensive documentation: Certificate of analysis, detailed synthesis report, and analytical data sheets accompany each shipment.

Integrate Tesamorelin into your experimental toolkit to explore GHRH‑mediated mechanisms with confidence. Its high degree of chemical fidelity and robust quality documentation make it an ideal candidate for studies ranging from signal transduction assays to in‑vitro hormone release models. By providing a reliable synthetic substitute for the native hormone, Tesamorelin helps streamline protocol development and enhances the reproducibility of your research outcomes.